Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
618
Value
$10.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NTLA by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026618$10.5K<0.1%00.0%UnchangedHolders
Q1 2026618$7.92K<0.1%00.0%UnchangedHolders
Q4 2025618$5.56K<0.1%00.0%UnchangedHolders
Q3 2025618$10.7K<0.1%00.0%UnchangedHolders
Q2 2025618$5.80K<0.1%+380+159.7%AddedHolders
Q1 2025238$1.69K<0.1%−85−26.3%ReducedHolders
Q4 2024323$3.77K<0.1%+317+5,283.3%AddedHolders
Q3 20246$123<0.1%−33−84.6%ReducedHolders
Q2 202439$873<0.1%−36−48.0%ReducedHolders
Q1 202475$2.06K<0.1%−192−71.9%ReducedHolders
Q4 2023267$8.14K<0.1%−22−7.6%ReducedHolders
Q3 2023289$9.14K<0.1%+50+20.9%AddedHolders
Q2 2023239$9.75K<0.1%−49−17.0%ReducedHolders
Q1 2023288$10.7K<0.1%+114+65.5%AddedHolders
Q4 2022174$6.07K<0.1%−4−2.2%ReducedHolders
Q3 2022178$10.0K<0.1%+1+0.6%AddedHolders
Q2 2022177$9.00K<0.1%−23−11.5%ReducedHolders
Q1 2022200$14.0K<0.1%+1+0.5%AddedHolders
Q4 2021199$24.0K<0.1%−66−24.9%ReducedHolders
Q3 2021265$36.0K<0.1%+141+113.7%AddedHolders
Q2 2021124$20.0K<0.1%−26−17.3%ReducedHolders
Q1 2021150$12.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.